Company Name, Ticker, Competitors, else..

Quanex Building Products Corporation (NX)

Other Ticker:

Sector • Basic Materials Industry • Miscellaneous Fabricated Products

Industry • Miscellaneous Fabricated Products

Sector • Basic Materials

A comfortable 5.403%, rise in Revenues at in the most recent fiscal period

recorded fourth quarter of 2022 operating surplus of $28.57 millions

Published 2022-12-17T17:46:09+00:00
Goran Soko / CSIMarket.com Contributer

Revenue for the fourth quarter of 2022 earnings season increased by 5.403 % to $307.53 millions relative to $291.77 millions in the prior year reporting season, bottom-line were up by 20.97 % to $0.75, as comparison at $0.62 in the prior year reporting season.

Revenue decreased by -5.094 % from $324.04 millions in prior period, EPS decreased by -3.85 % from $0.78 per share.

Bottom-line of $24.667 millions in the fourth quarter of 2022 earnings season increased by 18.04 % from net earnings of $20.898 millions reported in the fourth quarter of 2022 earnings season a year ago. This led to net margin improvement to 8.02%, while NX's operating margin stood at 9.29%, NX said.
Operating earnings, on the other hand, improved just 5.45% to $28.57 millions. Looking further into company's numbers for the financial period 2022, disclosed Revenues of $1.22 billions and net income of $88.34 millions.

Miscellaneous Fabricated Products company voiced also, that Eps soared by 56.47 % to $2.66 per share from $1.70 in the preceding financial period , industry's contribution addsRevenues advanced by 13.93 % from $1.07 billions a year before.

Quanex Building Products Corporation is expected to report next financial results on June 02, 2023.

Quanex Building Products Corporation Suppliers

Quanex Building Products Corporation Revenue improvement Rates

Recently Reported Results

Lowes Companies Inc

Lowes Companies Inc disclosed a moderate 5.178%, an increase in their Revenues, in the most recent fiscal period

The Home Improvement company delivered conflicting results in the most recent fiscal period, where Revenue rose by 5.178 % to $22.45 billions compared to $21.34 billions on a year-over-year basis, while income fell by -10.54 % to $1.57 per share, off $1.76 in the prior year financial reporting period.

Lowes Companies Inc stock quotes, charts, profile

Lowes Companies Inc Revenue rise Rates

Montage_By_Michael_Schmahl_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons

Construction Spending

Construction spending rebounded in January 2023

Outlays for U.S. construction projects increased again after dipping in the last month, led by growth in construction outlays for health care, residential and nonresidential construction.

Construction spending by category

Growth in construction outlays

National_Flood_Insurance-Flood_Smart_booth_pd

Conifer Holdings Inc

A modest 3.692%, rise in Revenues at the company over the fiscal span closing Dec 31 2022

For the October to December 31 2022 time-frame company had turn a round to profits by posting Income per Share of $0.15 per share compare to $-0.08 a year prior and EPS turned positive from $-0.14 per share from the previous reporting season.

Revenue increased moderate by 3.692 % to $28.50 millions from $27.49 millions in the comparable reporting season a year prior and sequentially Revenues advanced by 8.232 % from $26.34 millions.

Conifer Holdings Inc Competitors, Market Share

Conifer Holdings Inc improvement Rates, Profitability, PE

pills_rapid_release_pills_By_Katy_Warner_from_Orlando_FL_USA_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons

Reneo Pharmaceuticals Inc

Existing costs were increasing at the Reneo Pharmaceuticals Inc in the financial period ending December 31 2022

Following the bellwethers in the Major Pharmaceutical Preparations sector, a few lesser known businesses are publishing the earnings. RPHM mentioned it has clinched operating shortfall of $-14.562 millions, for the fourth quarter of 2022.

Reneo Pharmaceuticals Inc Customers

Reneo Pharmaceuticals Inc Income Statement, Balance sheets, Cash Flow Statement

Autosample_takes_a_By_Hey_Paul_(originally_posted_to_Flickr_as_image4)_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons

Impel Pharmaceuticals Inc

In the Dec 31 2022 report company decreased a loss per share at $-0.98 per share, opposite of $-1.06 per share a year ago quarter, In the prior quarter Impel Pharmaceuticals Inc realized $-1.31 per share.

Impel Pharmaceuticals Inc stock quotes, charts, profile

Impel Pharmaceuticals Inc Suppliers

Loxley_Farm_Market_Produce_By_Infrogmation_of_New_Orleans_[CC-BY-SA-3.0_(http_creativecommons.org_licensesby-sa3.0)]_via_Wikimedia_Commons

Consumer Price Index

Inflation on the rise again in January 2023

U.S. Consumer prices rose again after dipping in the last month, led by increase in gasoline prices.

Employment Report

Economy gains 223,000 jobs, unemployment rate 3.5 %

The nonfarm payrolls grew 223,000 in December, as faster hiring puts more money in the hands of consumers, what usually leads to an increase in spending,

Housing Starts

Cytomx Therapeutics Inc

Considering the October to December 31 2022 period the Major Pharmaceutical Preparations company lost money at $-0.42 per share, relative to the results of $-0.91 per share a year before quarter, In the preceding quarter the Cytomx Therapeutics Inc realized $-0.35 per share.

Cytomx Therapeutics Inc stock quotes, charts, profile

Cytomx Therapeutics Inc improvement Rates, Profitability, PE

Acer Therapeutics Inc

For the October to December 31 2022 period Acer Therapeutics Inc increased a loss per share of $-0.54 per share compare to $-0.30 a year prior and grew loss from $-0.31 per share from the prior reporting season.

Revenues remained unscathed to $0.00 millions from $0.36 millions in the comparable reporting season a year prior and sequentially Revenue Tumbled from $0.00 millions.

Acer Therapeutics Inc Competitors, Market Share

Acer Therapeutics Inc Suppliers

Pennsylvania Real Estate Investment Trust

Revenues receded by -5.307 %, at the company in the financial fourth quarter of 2022

For the fourth quarter of 2022 earnings season company Losses have extended of $-7.81 per share compare to $-0.43 a year prior and EPS improved from $-14.52 per share from the prior reporting season.

Revenues depreciated by -5.307 % to $80.65 millions from $85.17 millions in the same reporting season a year prior and sequentially Revenues advanced by 10.767 % from $72.81 millions.

Pennsylvania Real Estate Investment Trust Suppliers

Terns Pharmaceuticals Inc

For the fourth quarter of 2022 earnings season Terns Pharmaceuticals Inc decreased a loss per share of $-0.23 per share compare to $-0.56 a year before and EPS improved from $-0.44 per share from the preceding reporting season.

Revenues remained unscathed to $0.00 millions from $1.00 millions in the corresponding reporting season a year before and sequentially Revenues advanced from $0.00 millions.

Terns Pharmaceuticals Inc stock quotes, charts, profile

Terns Pharmaceuticals Inc Suppliers

Gold Royalty Corp

For the October to December 31 2022 period Gold Royalty Corp lost money of $-0.14 per share compare to $-0.14 a year before and from $0.00 per share from the prior reporting season.

Revenues remained unaltered by 0 % to $3.94 millions from $3.94 millions in the similar reporting season a year before and sequentially Revenues advanced from $0.00 millions.

Gold Royalty Corp stock quotes, charts, profile

Gold Royalty Corp elevation Rates, Profitability, PE

NASDAQ_studio_By_Luis_Villa_del_Campo__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons

P10 Inc

Shifting our attention to the financial fourth quarter of 2022 PX earnings turned positive at $0.03 per share, relative to the recent numbers of $-3.47 per share a year before reporting season, In the preceding reporting season PX realized $0.05 per share.

P10 Inc Customers

P10 Inc Revenue elevation Rates

Other NX's Earnings Reports

Quanex Building Products reported third quarter 2022 earnings

Quanex Building Products reported second quarter 2022 earnings

Quanex Building Products reported first quarter 2022 earnings

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071


Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar SO's Profile Stock Price SO's Financials Business Description Fundamentals Charts & Quotes SO's News Suppliers SO's Competitors Customers & Markets Economic Indicators SO's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness